Hims & Hers Health (DE:82W)
FRANKFURT:82W
Holding DE:82W?
Track your performance easily

Hims & Hers Health (82W) Income Statement

8 Followers

Hims & Hers Health Income Statement

Last quarter (Q3 2024), Hims & Hers Health's total revenue was $401.56M, an increase of 77.13% from the same quarter last year. In Q3, Hims & Hers Health's net income was $75.59M. See Hims & Hers Health’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.24B$ 872.00M$ 526.92M$ 271.88M$ 148.76M$ 82.56M
Cost of Revenue
$ 234.34M$ 157.05M$ 118.19M$ 67.38M$ 39.31M$ -37.95M
Gross Profit
$ 1.01B$ 714.95M$ 408.72M$ 204.49M$ 109.45M$ 44.60M
Operating Expense
$ 964.75M$ 744.40M$ 477.42M$ 319.54M$ 124.59M$ -119.02M
Operating Income
$ 42.91M$ -29.45M$ -68.70M$ -115.04M$ -15.14M$ -710.08K
Net Non Operating Interest Income Expense
----$ -10.00K$ 1.86M
Other Income Expense
$ 8.11M$ 7.88M$ 2.99M$ -445.00K$ -268.00K-
Pretax Income
$ 51.62M$ -21.57M$ -65.71M$ -110.80M$ -17.99M$ -71.97M
Tax Provision
$ -49.64M$ 1.98M$ -31.00K$ -3.14M$ 127.00K-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 101.26M$ -23.55M$ -65.68M$ -107.66M$ -18.11M$ 1.15M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 1.20B$ 901.45M$ 595.61M$ 386.92M$ 163.90M$ -156.97M
Net Income From Continuing And Discontinued Operation
$ 101.26M$ -23.55M$ -65.68M$ -107.66M$ -18.11M$ 1.15M
Normalized Income
$ -15.11M-----
Interest Expense
------
EBIT
$ 105.69M$ -21.57M$ -68.70M$ -115.04M$ -15.14M$ -71.97M
EBITDA
$ 119.37M$ -12.06M$ -61.22M$ -110.97M$ -14.09M$ -71.97M
Currency in USD

Hims & Hers Health Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis